These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5005 related articles for article (PubMed ID: 6233772)

  • 1. Abrogation of anterior-chamber-induced suppression of delayed-type hypersensitivity responses by monoclonal anti-I-J antibodies.
    Niederkorn JY; Waltenbaugh C; Streilein JW
    Transplantation; 1984 Jun; 37(6):623-5. PubMed ID: 6233772
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye.
    Ashour HM; Niederkorn JY
    Int Arch Allergy Immunol; 2007; 144(4):343-6. PubMed ID: 17671393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imposing deviant immunity on the presensitized state.
    Kosiewicz MM; Okamoto S; Miki S; Ksander BR; Shimizu T; Streilein JW
    J Immunol; 1994 Oct; 153(7):2962-73. PubMed ID: 8089480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
    Kosiewicz MM; Streilein JW
    J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular immune responses. I. Priming of A/J mice in the anterior chamber with azobenzenearsonate-derivatized cells induces second-order-like suppressor T cells.
    Wetzig RP; Foster CS; Greene MI
    J Immunol; 1982 Apr; 128(4):1753-7. PubMed ID: 6460810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
    Benson JL; Niederkorn JY
    Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
    Niederkorn JY; Streilein JW
    J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulation and the eye: a dangerous compromise.
    Streilein JW
    FASEB J; 1987 Sep; 1(3):199-208. PubMed ID: 2957263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed cellular immunity in mice harboring intraocular melanomas.
    Niederkorn JY
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):447-54. PubMed ID: 6608506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition".
    Niederkorn JY; Mayhew E; He Y
    Transplantation; 1995 Aug; 60(4):348-54. PubMed ID: 7652764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 251.